ELOX
Eloxx Pharmaceuticals, Inc.
+0.41 (+2.33%)18.04USD6.5K成交股數72.8M市值5.1本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q2 | 25Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 | 22Q3 | 22Q2 | 22Q1 | 21Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 2.8M | 1.7M | 898K | 510K | 1.5M | 1.3M | 2.3M | 3.5M | 4.9M | 7.7M | 7.9M | 7.9M |
| 銷售管理費用 | 1.6M | 2.1M | 684K | 712K | 2.5M | 2.4M | 1.8M | 2.0M | 2.3M | 2.6M | 3.1M | 3.7M |
| 營業利益 | −4.5M+10% | −3.8M+4% | −1.6M-62% | −1.2M-78% | −4.0M-44% | −3.6M-65% | −4.1M-62% | −5.5M-53% | −7.1M | −10.3M | −11.0M | −11.6M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −4.5M+56% | −3.8M+5% | −1.9M-56% | −1.7M-73% | −2.9M-61% | −3.6M-66% | −4.3M-63% | −6.2M-48% | −7.5M | −10.6M | −11.6M | −12.1M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.66-99% | -0.86-34% | -5.45+178% | -4.94+72% | -66.83+1826% | -1.31-73% | -1.96-63% | -2.88-92% | -3.47 | -4.90 | -5.36 | -37.28 |
| 稀釋股數 | 6.8M | 4.4M | 347K | 346K | 234K | 2.7M | 2.2M | 2.2M | 2.2M | 2.2M | 2.2M | 1.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q2 | 25Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 | 22Q3 | 22Q2 | 22Q1 | 21Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 62.0M | 6.4M | 572K | 450K | 1.1M | 4.8M | 4.3M | 4.9M | 24.6M | 30.0M | 39.8M | 42.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 63.4M | 8.5M | – | – | 1.7M | 6.0M | 6.0M | 7.2M | 26.9M | 32.9M | 43.6M | 45.1M |
| 有息負債 | – | – | – | – | 1.6M | 2.6M | 3.3M | 4.0M | 9.9M | 11.1M | 12.1M | 12.0M |
| 總負債 | – | – | – | – | 24.3M | 26.1M | 24.6M | 23.5M | 31.9M | 31.1M | 31.9M | 22.8M |
| 股東權益 | 46.4M | −7.6M | −27.9M | −26.0M | −22.6M | −20.0M | −18.6M | 16.3M | −5.0M | 1.8M | 11.7M | 22.4M |
| 負債比 | – | – | – | – | 1,420.0% | 431.8% | 410.3% | 326.3% | 118.5% | 94.5% | 73.2% | 50.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | −478K | 2.2M | 997K | 877K | 14.7M | 18.9M | 27.6M | 30.3M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q2 | 25Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 | 22Q3 | 22Q2 | 22Q1 | 21Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −5.5M | – | 1.2M-118% | – | – | – | −6.8M | – | – | −9.5M | – |
| 資本支出 | – | – | – | – | – | – | – | 0.00 | – | – | 11K | – |
| 自由現金流 | – | – | – | – | – | – | – | −6.8M | – | – | −9.5M | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | -100.0% | −6.0M | –% | -5.34 | – |
| FY2024 | 6.4M | – | −3.1M | -49.4% | -9.20 | – |
| FY2023 | 0.00 | – | −17.1M | –% | -72.98 | – |
| FY2022 | – | – | −36.1M | –% | -16.65 | −31.9M |
| FY2021 | – | – | −66.7M | –% | -38.15 | −35.1M |
| FY2020 | – | – | −34.6M | –% | -0.86 | – |
| FY2019 | – | – | −50.9M | –% | -1.34 | −39.4M |
| FY2018 | – | – | −47.2M | –% | -1.45 | −31.6M |